Brucella cyclic β-1,2-glucan plays a critical role in the induction of splenomegaly in mice by Roset, Mara Sabrina et al.
Brucella Cyclic b-1,2-Glucan Plays a Critical Role in the
Induction of Splenomegaly in Mice
Mara S. Roset1*, Andre´s E. Iban˜ez2, Job Alves de Souza Filho3, Juan M. Spera1, Leonardo Minatel1,
Sergio C. Oliveira3, Guillermo H. Giambartolomei2, Juliana Cassataro1, Gabriel Briones1*
1 Instituto de Investigaciones Biotecnolo´gicas ‘‘Rodolfo Ugalde’’ - Instituto Tecnolo´gico de Chascomu´s (IIB-INTECH), Universidad Nacional de San Martı´n (UNSAM), Consejo
Nacional de Investigaciones Cientı´ficas y Te´cnicas (CONICET), Buenos Aires, Argentina, 2 Laboratorio de Inmunogene´tica, INIGEM-CONICET, Hospital de Clı´nicas ‘‘Jose´ de
San Martı´n,’’ Facultad de Medicina, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina, 3Department of Biochemistry and Immunology, Institute of Biological
Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Abstract
Brucella, the etiological agent of animal and human brucellosis, is a bacterium with the capacity to modulate the
inflammatory response. Cyclic b-1,2-glucan (CbG) is a virulence factor key for the pathogenesis of Brucella as it is involved in
the intracellular life cycle of the bacteria. Using comparative studies with different CbG mutants of Brucella, cgs (CbG
synthase), cgt (CbG transporter) and cgm (CbG modifier), we have identified different roles for this polysaccharide in Brucella.
While anionic CbG is required for bacterial growth in low osmolarity conditions, the sole requirement for a successful
Brucella interaction with mammalian host is its transport to periplasmic space. Our results uncover a new role for CbG in
promoting splenomegaly in mice. We showed that CbG-dependent spleen inflammation is the consequence of massive cell
recruitment (monocytes, dendritics cells and neutrophils) due to the induction of pro-inflammatory cytokines such as IL-12
and TNF-a and also that the reduced splenomegaly response observed with the cgs mutant is not the consequence of
changes in expression levels of the characterized Brucella PAMPs LPS, flagellin or OMP16/19. Complementation of cgs
mutant with purified CbG increased significantly spleen inflammation response suggesting a direct role for this
polysaccharide.
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Introduction
Brucella is a bacterial pathogen that infects ruminants as the
primary host and can be transmitted to humans by consumption of
animal-derived contaminated products (e.g. unpasteurized dairy
food) leading to brucellosis, a reticular endothelial disease,
typically characterized by undulant fever [1]. Brucella, as the result
of a longstanding association with the mammalian host, has
evolved modified PAMPs (pathogen-associated molecular patterns
molecules) such LPS and flagellin. These modified PAMPs limit
host recognition by innate immune receptors (TLRs and NLRs)
during the acute phase of the infectious process, reducing the
induction of the inflammatory response known to be necessary for
an efficient control of the infection [2–4]. In addition Brucella
expresses virulence factors that actively interfere with the innate
immune response such as the Brucella proteins Btp-A/TcpB and
BtpB that down-regulate TLR2/TLR4 signaling [5–7]. Paradox-
ically, when the host is persistently infected at the chronic phase of
brucellosis, inflammation becomes a dominant clinical sign that
has been described to affect several organs producing symptoms
such as arthritis, endocarditis, meningitis, epididymitis and
splenomegaly [8].
To date few virulence mechanisms have been described in
Brucella infection and different genomic studies have confirmed the
absence of classical virulence factors like fimbriae, pilli, toxins or
plasmids [9,10]. In our laboratory, we have identified and
characterized a critical molecule for Brucella virulence: the cyclic
b-1,2-glucan (CbG). CbG is composed by a family of cyclic
polymers of 17 to 25 D-glucose molecules linked by b-1,2 linkages,
synthesized by a membrane bound enzyme named Cgs (for cyclic
glucan synthase) that utilizes UDP-glucose as the sugar donor [11].
Cgs initiates and elongates a linear chain of glucoses covalently
bound to the Cgs which is subsequently cyclated and released to
the bacterial cytoplasm [12]. A specific Brucella ABC-transporter
Cgt (for Cyclic glucan transporter) translocates the CbG to the
periplasmic space where they become chemically modified with
the addition of succinyl groups, a reaction catalyzed by the
membrane enzyme Cgm (for Cyclic glucan modifier) [13,14].
Although CbG is present within the periplasmic space, being this
localization critical for hypo-osmotic adaptation, secretion of large
amount of this polysaccharide to the supernatant by a non-
characterized mechanism has been described in Agrobacterium and
Sinohizobium [15]. Interestingly, Brucella cgs mutant strain presents a
defect in intracellular trafficking in epithelial cells that can be
complemented by the addition of purified CbG (or Cyclodextrins)
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to tissue culture medium [16]. This observation suggests that also
in Brucella, CbG must be secreted within the host cell to exert its
role in virulence. The proposed mechanism of action for CbG in
Brucella infection is the sequestration of cholesterol from intracel-
lular host membranes leading to lipid raft disorganization and
modulation of intracellular trafficking [16].
We have previously observed that mice infected with a cgs
mutant had a reduced spleen inflammatory response even though
they had a high number of replicating bacteria within this organ
[17]. Since inflammation is the consequence of the host
recognition of microbial PAMPs that ultimately lead to the
induction of an inflammatory process, we hypothesized that either
the periplasmic CbG may be stabilizing the expression of Brucella
PAMPs such as LPS, flagellin, and OMPs or that CbG could be
recognized by the innate immune receptors in the context of
Brucella infection triggering inflammation.
It has been shown recently, using in vitro studies and purified
CbG, that this molecule acts directly as an agonist of the innate
immune system mediated by TLR4 in a MyD88/TRIF dependent
fashion (and in a CD14 independent manner) [18]. Here we
describe the role of Brucella CbG in splenomegaly and inflamma-
tion.
Materials and Methods
Ethics statement
The protocol of this study (reference number 10/2011) was
approved by the Committee on the Ethics of Animal Experiments
of the Universidad Nacional de San Martı´n, which also approved
protocol development under the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National
Institutes of Health.
Growth of B. abortus
Bacterial strains used in this study were: Brucella abortus strain
2308, Brucella abortus strain S19, Brucella abortus cgs08 mutant,
Brucella abortus cgs19 mutant [17]; Brucella abortus cgt19 mutant [13]
and Brucella abortus cgm19 mutant [14]. All experiments involving
live B. abortus were conducted in a biosafety level 3 (BSL3) facilities
at the University of San Martı´n, Buenos Aires, Argentina. B.
abortus strains were grown at 37uC on tryptic soy agar (TSA) and in
tryptic soy broth (TSB) on a rotary shaker (250 rpm). If necessary,
culture media were supplemented with the appropriate antibiotics
at the following concentrations: kanamycin (Km), 50 mg/ml;
ampicillin (Amp), 100 mg/ml; and nalidixic acid (Nal), 5 mg/ml.
CbG purification from B. abortus
For preparative purposes, 6-liter of stationary-phase cultures of
B. abortus S19 grown for 48 h at 37uC (250 rpm) were harvested by
centrifugation at 10,0006g for 10 min. The pellets were extracted
with ethanol (70% ethanol; 1 h at 37uC). The ethanolic extracts
were centrifuged and the supernatants were dried in a speed-vac
centrifuge and subjected to Bio-Gel P4 chromatography and
HPLC on a C18 silica column for further purification as described
previously [14]. Purity of CbG was confirmed by NMR analysis
[14]. Thin-layer chromatography (TLC) was performed as
previously describe [12].
Western blot analysis
To monitor the expression levels of outer membrane proteins
and LPS in B. abortus strains, bacteria were grown in TSB and
harvested at stationary phase. Equivalent bacterial pellets were
resuspended in Laemmli buffer and samples were subjected to
SDS-PAGE. Proteins were transferred onto nitrocellulose mem-
branes using a semi-dry transfer procedure. Immunoblotting was
performed using mouse monoclonal antibodies against Omp16
and Omp19 (kindly provided by Dr. Axel Cloeckaert) and mouse
anti-O-polysaccharide monoclonal antibody M84 (kindly provided
by Dr. K Nielsen). The correct O-antigen display on the
membrane of B. abortus was confirmed by a Brucella phage
sensitivity test (Tbs, Rcr) and crystal violet staining [30].
In order to detect the expression of flagellin in B. abortus strains,
bacteria were grown in 2YT medium [19] and harvested at early
log phase (OD600 0.2). Equivalent bacterial pellets were resus-
pended in Laemmli buffer and samples were subjected to 12%
SDS-PAGE. Proteins were transferred as described above.
Immunoblotting was performed using rabbit polyclonal antibodies
against Brucella flagellin (kindly provided by Dr. J J Letteson).
Effect of the osmolarity on B. abortus growth
All strains were grown in regular LB (170 mM NaCl) until
stationary phase. Cultures were harvested by centrifugation
(12,5006g for 5 min) and washed twice with PBS. Cells were
suspended to an OD600 of 0.9 and serially diluted in PBS, and
10 ml of the dilutions were spotted on LB agar or LB agar without
the addition of NaCl. The plates were incubated at 37uC for 5
days before being read.
B. abortus virulence in mice
Virulence was determined by quantitating Brucella survival in
mouse spleens at two weeks postinfection, as previously described
[20]. Groups of 9-week-old female BALB/c mice were intraper-
itoneally (i.p) injected with different doses of B. abortus strains in
0.2 ml of sterile PBS. The animals were euthanized, and the
spleens were removed, weighed, homogenized in PBS, serially
diluted, and plated onto TSA with the appropriate antibiotics to
determine the number of CFU per spleen.
Complementation of B. abortus cgs mutant with purified
CbG
Mice were i.p inoculated with 16106 CFU of B. abortus S19 or
16106 CFU of its isogenic strain B. abortus cgs mutant. Sets of five
mice inoculated with B. abortus cgs mutant were i.p injected with
15 mg of purified CbG during the first five days of infection. At two
weeks postinfection, the animals were euthanized, and the spleens
were removed, weighed, homogenized in PBS, serially diluted, and
plated onto TSA with the appropriate antibiotics to determine the
number of CFU per spleen.
Histological analysis of spleens infected with B. abortus
Group of mice were i.p infected with 16106 CFU of B. abortus
S19 or its isogenic B. abortus cgs mutant strain. At two weeks
postinfection spleens were excised, fixed with 10% neutral buffered
formalin and paraffin embedded. Finally, four micrometers thick
longitudinal sections of spleens were obtained and stained with
hematoxylin and eosin to assess the degree of spleen inflammation.
Preparation of single-cell suspensions of spleens infected
with B. abortus
Spleens were aseptically removed and single cell suspensions
were prepared by gently teasing through a sterile stainless steel
screen. Erythrocytes were lysed in red blood cell lysis buffer and
cells were washed twice in PBS solution.
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Determination of inflammatory cell recruitment in
spleens infected with B. abortus
BALB/c mice were infected with 16106 CFU of B. abortus S19
or its isogenic B. abortus cgs mutant strain. Spleens were obtained at
two weeks postinfection and single cell suspensions were prepared.
To assess recruitment of different cell subtypes after infection,
splenocytes (26106) were stained with anti-CD4 (FITC), -CD8
(PE-Cy5), -CD11c (PE), -CD11b (PE-Cy7), -Ly6G (PE), -Ly6C
(PerCP-Cy5.5) and -B220 (PE) and analyzed by flow cytometry
using FACSAriaII (BD Biosciences, San Jose, CA) and FlowJo
software (Tree Star, Ashland, OR). Monoclonal antibodies were
purchased from eBioscience (San Diego, CA) and BD Biosciences
(San Jose, CA).
Figure 1. Different roles for Brucella CbG. (A) Schematic representation of Brucella CbG biosynthesis in the wild type strain and its isogenics CbG
mutants strains, cgs, cgt and cgm. Inset pictures show TLC analysis of neutral (**) and anionic (*) CbG. Cgs: Cyclic b-1,2-glucan synthase, Cgt: Cyclic b-
1,2-glucan transporter, Cgm: Cyclic b-1,2-glucan modifier. IM: Inner membrane, OM: outer membrane, OMP: outer membrane protein, UDP- : uridine
diphospho-glucose, LPS: Lipopolysaccharide. (B) Effect of osmolarity on growth of different strains of B. abortus. Dilutions were spotted on LB agar
(170 mM NaCl) or LB agar without the addition of NaCl. The plates were incubated at 37uC for 5 days before determining CFU. (C) CbG mutant strains
phenotype during Brucella-host interaction. Intracellular replication was monitored in HeLa cells at 48 h p.i and establishment of chronic infection of
Brucella was evaluated in BALB/c mice by determining spleen CFU at six weeks p.i.
doi:10.1371/journal.pone.0101279.g001
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Determination of cytokines in bone-marrow derived
macrophages (BMDM) infected with B. abortus strains
Macrophages were derived from bone marrow of C57BL/6,
Mal/tirap, TLR4, TLR6 and TLR9 KO mice as follows. Each
femur and tibia was flushed with 5 ml of Hank’s balanced salt
solution (HBSS). The resulting cell suspension was centrifuged,
and the cells were resuspended in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco, Grand Island, NY) containing 10% fetal
bovine Serum (FBS; Gibco), 1% penicillin/streptomycin (100 mg/
mL) and 10% L929 cell-conditioned medium (LCCM) as a source
of macrophage colony-stimulating factor (M-CSF). The cells were
distributed in 24-well plates and incubated at 37uC in a 5% CO2
atmosphere. Three days after seeding, another 0.1 ml of LCCM
was added. On the seventh day, the medium was renewed. On the
10th day of culture, the cells were completely differentiated into
macrophages [21]. The BMDM were infected with B. abortus S19
or its isogenic B. abortus cgs mutant strain, corresponding to a
multiplicity of infection (MOI) of 100:1. After 60 min incubation
with the bacteria, wells were washed three times with phosphate-
buffered saline (PBS) and incubated with fresh medium containing
50 mg ml21 Gm and 100 mg ml21 streptomycin to kill non-
internalized bacteria After 24 h postinfection, the level of IL-12
(p40) and TNFa in the supernatants of BMDM were measured by
ELISA Duoset kit (R&D, Minneapolis, MN). At 4, 24 and
48 hours postinfection, infected C57BL/6 BMDM were washed
three times with PBS and lysed with 500 ml 0.1% Triton X-100
(Sigma-Aldrich Co.). The intracellular CFU was determined by
plating serial dilutions on TSA with the appropriated antibiotic.
Results and Discussion
Transport of Brucella CbG to periplasm is required for
bacterial-host interaction
As shown in Fig. 1A–a, Cgs, a 320 kDa membrane bound
enzyme (the second largest protein in Brucella), is the enzyme
responsible for the synthesis of cytoplasmic CbG, which is
afterwards translocated to the periplasmic space by Cgt, a CbG-
specific ABC transporter, and modified with succynil groups by
the activity of Cgm (Fig. 1A–a). In order to determine if the
different biosynthetic intermediate states of CbG play differential
Figure 2. B. abortus cgs and cgt mutants elicit a reduced
splenomegaly in mice. BALB/c mice were intraperitoneally infected
(16106 CFU) with (A) B. abortus 2308 or (B) B. abortus S19 and their
isogenic CbG mutant strains. At two weeks postinfection, spleens were
removed, weighed (right panel) and the numbers of CFU recovered
were determined by serial dilutions and plating onto TSA (left panel).
Five animals were used for each determination. *, P,0.05; **, P,0.01,
Mann-Whitney test.
doi:10.1371/journal.pone.0101279.g002
Figure 3. Splenomegaly induced by B. abortus is dependent on
the initial dose of infection. BALB/c mice were intraperitoneally
infected with different doses of B. abortus S19 or B. abortus cgs19
mutant. At two weeks postinfection, spleens were removed, weighed
and the numbers of CFU recovered from spleens determined by serial
dilutions and plating onto TSA. (A) Recovery of viable bacteria from
spleens of mice. (B) Spleens weight of infected mice. Bacterial doses
were calculated retrospectively by colony counting. *, P,0.05; **, P,
0.01, Mann-Whitney test.
doi:10.1371/journal.pone.0101279.g003
CbG-Dependent Splenomegaly
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Figure 4. Reduced splenomegaly elicited by cgs B. abortus infection is a consequence of a lesser degree of cell recruitment. (A) BALB/c
mice were intraperitoneally infected (16106 CFU) with B. abortus S19, B. abortus cgs19 mutant or PBS as a control. Mice were euthanized at two weeks
postinfection and spleens were removed and examined by histological analysis. WP: white pulp; RP: Red pulp; CA: central spleen artery, L:
CbG-Dependent Splenomegaly
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roles in the bacteria the phenotype of three different B. abortus
CbG mutants were compared: cgs [17], cgt [13] and cgm mutant
[14]. As shown in Fig. 1A–b, deletion of cgs gene abolished the
presence of CbG but mutations in cgt or cgm lead to the production
of neutral CbG (Fig. 1A–c and d) with a different cellular
localization being cytoplasmic in cgt mutant and periplasmic in the
case of cgm. From the comparison between cgt and cgm it became
evident that CbG plays at least two roles: adaptation to hypo-
osmotic growth conditions (Fig. 1B) and Brucella-host interaction
(Fig. 1C). While the adaptation to hypo-osmotic conditions
requires the presence of anionic periplasmic CbG (Fig. 1B), the
sole requirement for host-pathogen interaction is the transport of
CbG to the periplasmic space regardless of its anionic charge, as
demonstrated by the cgm phenotype in intracellular replication and
chronic infection in mice (Fig. 1C).
B. abortus mutants unable to produce CbG or to
transport it to the periplasm elicit a reduced
splenomegaly in mice
As we reported, deletion of cgs gene either in the wild type strain
B. abortus 2308 or in the vaccine strain B. abortus S19 (which is
virulent for humans) reduced their ability to infect mice and
hampered their efficiency to reach the intracellular replication
niche in epithelial cells [16,17]. Although attenuation of virulence
occurs in both Brucella backgrounds, in the S19 strain the
phenotype is already evidenced after 4 weeks postinfection while
in the 2308 background, attenuation is observed after 12 weeks
postinfection [17]. Interestingly, at two weeks postinfection when
the infection is still not resolved and the number of bacteria in the
spleens are equivalent (in the case of B. abortus cgs08 mutant,
Fig. 2A left panel) or slightly reduced (in the case of B. abortus cgs19
mutant, Fig. 2B left panel) compared to their respective wild type
parental strains, the splenomegaly was significantly reduced in
mice infected with both cgs isogenic mutants (Fig. 2A and 2B, right
panel). In an earlier report, Crawford et al. observed that
splenomegaly elicited by Brucella melitensis infection (which peaks
from two to three weeks postinfection) is dependent on the initial
dose of infection rather than on the bacterial burden, concluding
that very early events in the Brucella infection are the driving force
controlling the severity of the inflammatory response in the spleen
[22].
Since cgs mutants induced a reduced splenomegaly phenotype in
both B. abortus 2308 and B. abortus S19 backgrounds, we decided to
use the vaccine strain of B. abortus S19 for the next set of
experiments as the wild type control because it elicited a
significantly increased splenomegaly compared to the one induced
by the B. abortus 2308 strain [23] allowing us to develop a more
sensitive assay. Additionally, since B. abortus S19 presents an
intracellular trafficking defect in epithelial cells [24], similar to the
defect described for B. abortus cgs mutant strains, we reasoned that
the use of S19 as our wild type control would reduce also the
experimental variability due to differences in intracellular local-
ization. Fig 2B (right panel) shows that the B. abortus S19 and B.
abortus cgm19 mutant strains evoked a significantly increased
inflammatory response in the spleens in comparison with the
mutants B. abortus cgs19 and B. abortus cgt19, suggesting that
the splenomegaly correlated with the presence of CbG within the
periplasmic space. As mentioned above, CbG is likely secreted
within the host cell and therefore periplasmic localization
requirement might be potentially a prerequisite for its delivery
outside the bacteria.
Splenomegaly is dependent on the initial dose of B.
abortus infection
To study the impact of the initial dose of infection on the
intensity of the splenomegaly, BALB/c mice were intraperitoneally
infected with different doses of B. abortus S19 (103, 106 and
109 CFU) (Fig. 3) and after two weeks postinfection spleens were
removed, weighed, homogenized and the number of bacteria
determined by serial dilution and plating to determine CFUs.
Fig. 3 shows that, at two weeks postinfection although the numbers
of replicating B. abortus S19 recovered from spleens were similar
(about 106–107 CFU per spleen) (Fig. 3A), the splenomegaly
varied from negligible (about 0.1 grams) to a massive one (1 gram)
(Fig. 3B) depending on the initial dose of infection, confirming
previous observations in Brucella melitensis [22]. To estimate the
impact of cgs phenotype on spleen inflammation, we infected mice
with different doses of B. abortus cgs19 mutant strain and at two
weeks postinfection, splenomegaly was determined. The results
showed that, to achieve an equivalent degree of splenomegaly
elicited by 16106 B. abortus S19, it was necessary to increase a
thousand times the initial dose of the B. abortus cgs19 (16109)
(Fig. 3B).
lymphocytes, L-m: medium lymphocytes; L-lg: large lymphocytes, HC: Hematopoietic cells, N: neutrophils, M: macrophages, S: dilated sinuses. (B) The
number of differential counts of monocytes, neutrophils, dendritic cells (DCs) and B lymphocytes were determined as described in Materials and
Methods. *, P,0.05; **, P,0.01, t test.
doi:10.1371/journal.pone.0101279.g004
Figure 5. B. abortus CbG partially complement splenomegaly in
mice. BALB/c mice were intraperitoneally infected with 16106 CFU of
B. abortus S19 or 16106 CFU of B. abortus cgs19 mutant. Sets of five
mice inoculated with B. abortus cgs mutant were injected intraperito-
neally with 15 mg of purified CbG during the first five days of infection.
At two weeks postinfection, mice were euthanized, and spleens were
removed, weighed (A) and the number of CFU recovered determined
by serial dilutions and plating onto TSA (B). *, P,0.05, Mann-Whitney
test.
doi:10.1371/journal.pone.0101279.g005
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Reduced splenomegaly elicited by the cgs mutant is the
consequence of a lesser degree of cell recruitment
At two weeks postinfection spleens from Brucella infected mice
were processed for histological analysis and the results are shown
in Fig 4A. While spleens from wild type strain infected mice
showed an increase in the global cellularity with a massive
infiltration of the red and white pulp (Fig. 4A–c), spleens from cgs
infected mice shown a reduced degree of cellular infiltration
(Fig. 4A–b) similar to what was observed in spleens of non-infected
animals (Fig. 4A–a). Remarkably, at 4006 magnification, the
presence of neutrophils and macrophages within the red pulp of B.
abortus S19 infected mice was observed (Fig. 4A–i) indicating
massive cell recruitment to the spleen. In addition, spleen white
pulp of B. abortus S19 and B. abortus cgs19 infected mice presented
reactive lymphocytes (larger and medium lymphocytes) likely due
to antigen stimulation (Fig. 4A–e and f).
To further characterize the spleen cell population, antibodies
against specific markers were used to identified and quantify
neutrophils, monocytes, B cells, T cells and dendritic cells by flow
cytometry. As shown in Fig 4B spleens from B. abortus S19 infected
mice presented eight times more neutrophils, ten times more
monocytes, three times more dendritic cells and two times more B
cells than spleens infected with B. abortus cgs19 mutant strain. No
difference was observed in T-cell recruitment (not shown).
One possible explanation for the reduced splenomegaly and cell
recruitment associated with the lack of CbG biosynthesis or CbG
transport to the periplasm could be that cgs/cgt strains have a
differential expression of PAMPs that might lead to a less efficient
engagement of the host innate immune receptors and consequent-
ly to a diminished inflammatory response.
B. abortus cgs mutant has normal expression of flagellin and
Omps, displaying normal amounts of smooth LPS (S-LPS) on
the membrane
It has been demonstrated that Agrobacterium and Sinorhizobium cgs
mutants have a reduced expression of flagellin and a defect in
flagella assembly that consequently leads to a non-motile
phenotype [25] [26]. Since bacterial flagellins are powerful
agonists of innate immune receptors, being recognized extracel-
lularly by the surface receptor TLR-5 and intracellularlly by Nod-
like receptors (such Ipaf or Naip5) [2], we explored if the Brucella
cgs mutant has an altered expression of flagellin that might explain
the diminished inflammatory response. In Alphaproteobacteria
(including the Brucella genus) flagellin has a modification in the
protein domain recognized by the TLR-5 innate immune receptor
supporting the idea that Brucella flagellin has evolved to escape the
host innate immune recognition [2]. In addition, in Brucella,
flagellin expression is tightly controlled and only expressed under
very strict culture conditions [19] and, because it has never been
identified in any intracellular Brucella proteomic studies, this
suggests that it is expressed poorly within the host cell [27,28]. In
order to determine if the absence of periplasmic CbG affects
flagellin expression, B. abortus S19 and its isogenic cgs, cgt and cgm
mutants were grown in the conditional media to allow flagella
assembly as described in Materials and Methods. Expression of
Brucella flagellin was monitored by Western blot analysis, and the
results, shown in Fig. S1A, indicates no changes in flagellin
expression. Afterwards, we studied the expression of other critical
Brucella PAMPs such as OMP16, OMP19 [29] or LPS [3,4][31]
and no differences in expression were observed associated to any
B. abortus CbG mutant strains (Fig. S1A and S1B).
Purified Brucella CbG partially complemented the
splenomegaly defect in cgs-infected mice
As was mentioned above, purified CbG is capable to restore the
intracellular replication deficiency of cgs-mutant strain in HeLa
cells [16] and this observation suggests that CbG must be secreted
within the host cell to exert its role in virulence. To evaluate the
direct role of Brucella CbG in the inflammatory response we
designed a trans-complementation experiment using purified
CbG. For this, we added the purified carbohydrate to the
bacterial initial inoculum and during the following five days
postinfection by i.p injection. Splenomegaly determined at two
weeks postinfection showed an increase in spleen weight in the
CbG complemented mice compared to the cgs mutant although
Figure 6. B. abortus cgs mutant failed to induce IL-12 in BMDM.
(A) Intracellular multiplication of B. abortus strains in Bone marrow cells
derived from C57BL/6. Number of CFU of intracellular bacteria was
determined after lysis of infected cells at the indicated times
postinfection. Each determination was performed in duplicate, and
values are shown as the means 6 standard deviations and are
representative of three independent experiments. (B) Bone marrow cells
derived from C57BL/6, Mal/Tirap, TLR4, TLR6 or TLR9 KO mice were
infected with B. abortus (MOI 1:100). IL-12 and TNF-a were measured by
ELISA at 24 h postinfection. *, P,0.05; **, P,0.01, *** P,0.01 t test.
doi:10.1371/journal.pone.0101279.g006
CbG-Dependent Splenomegaly
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not to the degree of the Brucella wild type strain (Fig. 5A). Although
significant, trans-complementation with purified CbG elicits a
moderate increase on spleen enlargement compared with cgs
mutant strain, an effect that can be explained as the result of the
intrinsic limitations of this experimental approach. For instance,
since injected CbG is diluted within the peritoneal cavity is not
possible to know the effective CbG concentration at the Brucella
intracellular replicative niche. However, these results suggest that
Brucella CbG plays a direct role in the induction of the
inflammatory response in the spleen. It has been recently proposed
that purified Brucella CbG may act as a novel class of adjuvant that
can induce, in vitro, the activation of mouse and human dendritic
cells, enhancing T cell responses and CD4+ T cells memory
immune responses in a TLR4 dependent/CD14 independent
fashion [18]. Interestingly, it was described recently that inflam-
mation far from be an undesirable byproduct of the bacterial
infection can be a process that pathogens can actively promote to
create favorable conditions for its own advantage. Thus entero-
bacterial pathogens can outgrow commensal bacteria or promote
host release of compounds of nutritional relevance mediated by
the activity of its virulence mechanisms [32,33]. In that manner it
is conceivable to speculate that CbG dependent splenomegaly
might work as an advantage for host colonization in Brucella
infection.
B. abortus cgs mutant strain elicits a reduced
inflammatory response in BMDM
In previous studies, Zhan et al demonstrated that the macro-
phage-synthesized cytokines IL-12 and TNF-a are required for an
efficient control of Brucella infection. In addition, it was shown that
depletion of both pro-inflammatory cytokines by antibody
treatment abolished the development of splenomegaly in animals
infected with B. abortus S19 at two weeks postinfection [34]. To
understand if the reduced spleen inflammation observed in mice
infected with B. abortus cgs19 was due to a lower induction of IL-12
or TNF-a, we performed an in vitro infection experiment with
naı¨ve BMDM. Differently to the defective intracellular replication
phenotype reported for B. abortus cgs mutant strains in HeLa cells
[17], in BMDM B. abortus cgs19 mutant strain showed no defect in
intracellular replication in comparison with its parental wild type
strain (Fig. 6A). The same phenotype was also reported for cgs
mutant strain for intracellular replication in dendritic cells [5]. As
shown in Fig. 6B and 6C, wild type BMDM infected with B. abortus
S19, secreted higher levels of IL-12 (Fig. 6B) and TNF-a (Fig. 6C)
to the supernatant than cells infected with B. abortus cgs19 mutant
strain, suggesting that CbG promotes the induction of proin-
flammatory cytokines from BMDM. To understand if this CbG-
dependent IL-12/TNF-a induction is dependent on Toll-like
receptor (TLR) recognition, an in vitro experiment with BMDM
from Mal/Tirap (the TLR2/TLR4 adapter protein), TLR4,
TLR6 and TLR9 KO mice was performed (Fig. 6B and C). As
shown in Fig. 6B, CbG-dependent IL-12 induction was indepen-
dent on the presence of TLR2, TLR4, TLR6 or TLR9 (Fig 6B)
while CbG-dependent TNF-a induction was independent on the
presence of TLR4 or TLR9 (Fig. 6C). In absence of TLR2 or
TLR6, B. abortus S19 and its isogenic cgs mutant strain elicited
similar levels of TNF-a (Fig. 6C). These results suggest that TLR2
and TLR6 are potentially involved in the TNF-a induction elicited
by CbG. It is interesting to notice that TLR2 and TLR6 are able
to interact to form a heterodimer which is responsible for bacterial
deacylated lipoproteins recognition [35].
Taken together all these results suggest that the reduced
splenomegaly observed in cgs mutant strain infected mice is a
consequence of a lower induction of proinflammatory cytokines
that lead to a lesser cell recruitment to this organ.
Concluding Remarks
In the present study we describe the role of the Brucella cyclic b-
1,2-glucan in promoting spleen enlargement during bacterial
infection. Splenomegaly was the result of massive cell recruitment,
mediated by the induction of pro-inflammatory cytokines. Since
mutants deficient in CbG biosynthesis in the soil bacteria
Sinorhizobium and Agrobacterium have shown to have membrane
alterations that lead to non-motile phenotypes and an increased
sensitivity to dyes and detergents, we evaluated if the low-
inflammation phenotype observed with the cgs/cgt mutants was
due to changes in expression of membrane bound complexes with
inflammatory activity. No differences in flagellin, OMPs or LPS
expression were evident and results suggested that CbG per se is
responsible for the splenomegaly observed. The molecular
mechanism underlying CbG induced splenomegaly remains to
be identified and further studies will be performed to characterize
this process.
Supporting Information
Figure S1 Western blot analysis of flagellin, outer
membrane proteins (Omps) (A) and LPS (B) in B.
abortus CbG mutant strains. Immunoblotting was performed
using: rabbit polyclonal antibodies against Brucella flagellin,
monoclonal antibodies against Omp16 and Omp19; and O-
antigen specific monoclonal antibody (M84). SDS-PAGE and
Western blot were carried out as described in Materials and
Methods. The same amount of total protein extracts were loaded
into the gels. The estimated molecular weight of each protein is
shown.
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